Quinidine sulfate dihydrate

Quinidine Sulfate is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 2 investigational indications. Its therapeutic use is listed as antiarrhythmics and cardiovascular. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Quinicardine and Quinora. Its PubChem CID is 656862.

CAS No 6591-63-5
Molecular Formula C40H54N4O10S
Molecular Weight 782.9 g/mol
Synonyms bis((S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol);sulfuric acid;dihydrate

Frequently Asked Questions